Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia Report of a Who/idf Consultation Who Library Cataloguing-in-publication Data

Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia : report of a WHO/IDF consultation.

[1]  P. Bennett,et al.  Diabetes in the Pima Indians: Evidence of Bimodality in Glucose Tolerance Distributions , 1971, Diabetes.

[2]  P. Zimmet.  Bimodality of Fasting and Two-hour Glucose Tolerance Distributions in a Micronesian Population , 1978, Diabetes.

[3]  P. Zimmet,et al.  Bimodality in glucose tolerance distributions in the urban Polynesian population of Western Samoa. , 1984, Diabetes research.

[4]  S. Haffner,et al.  Evidence of bimodality of two hour plasma glucose concentrations in Mexican Americans: results from the San Antonio Heart study. , 1985, Journal of chronic diseases.

[5]  K. Alberti,et al.  What is Blood Glucose: Can it be Measured? , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[6]  A. Motala,et al.  South African Indians Show a High Prevalence of NIDDM and Bimodality in Plasma Glucose Distribution Patterns , 1994, Diabetes Care.

[7]  R. Hanson,et al.  Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes , 1994, BMJ.

[8]  M. Engelgau,et al.  Comparison of Fasting and 2-Hour Glucose and HbA1c Levels for Diagnosing Diabetes: Diagnostic criteria and performance revisited , 1997, Diabetes Care.

[9]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[10]  L. Bouter,et al.  Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study , 1999, Diabetologia.

[11]  J. Shaw,et al.  Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality , 1999, Diabetologia.

[12]  B. Balkau,et al.  Is there a glycemic threshold for mortality risk? , 1999, Diabetes care.

[13]  R. Hanson,et al.  The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. , 2000, Diabetes care.

[14]  R. Hanson,et al.  Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. , 2000, Diabetes care.

[15]  J. Shaw,et al.  Impaired fasting glucose: how low should it go? , 2000, Diabetes care.

[16]  C. Ito,et al.  Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. , 2000, Diabetes research and clinical practice.

[17]  B. Balkau,et al.  From policemen to policies: what is the future for 2-h glucose? The Kelly West Lecture, 2000. , 2001, Diabetes care.

[18]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[19]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[20]  T. Buchanan,et al.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.

[21]  Maimunah A Hamid,et al.  Bimodality in blood glucose distribution: is it universal? , 2002, Diabetes care.

[22]  Beverley Balkau,et al.  Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. , 2003, Diabetes care.

[23]  T. Jørgensen,et al.  Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. , 2003, Diabetes care.

[24]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[25]  J. Tuomilehto,et al.  Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? , 2003, Diabetes care.

[26]  E. Ford,et al.  Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. , 2004, Archives of internal medicine.

[27]  Y. Nose,et al.  Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study , 2004, Diabetologia.

[28]  L. Sjöström,et al.  XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. , 2004, Diabetes care.

[29]  L. Bouter,et al.  Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study , 1996, Diabetologia.

[30]  K. Borch-Johnsen,et al.  Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms , 2004, Diabetologia.

[31]  J. Després,et al.  What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. , 2004, Diabetes care.

[32]  Charles M Peterson,et al.  Tests of glycemia in diabetes. , 1995, Diabetes care.

[33]  I. Godsland,et al.  Loss of beta cell function as fasting glucose increases in the non-diabetic range , 2004, Diabetologia.

[34]  J. Meigs,et al.  Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. , 2004, Diabetes.

[35]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[36]  J. Shaw,et al.  High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius , 2004, Journal of internal medicine.

[37]  C. Snehalatha,et al.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) , 2006, Diabetologia.

[38]  Katsuhiko Kuwa,et al.  Approved IFCC recommendation on reporting results for blood glucose (abbreviated). , 2005, Clinical chemistry.

[39]  E. Vierron,et al.  Comment to: Borch-Johnsen K, Colagiuri S, Balkau B et al. (2004) Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47:1396-1402. , 2005, Diabetologia.

[40]  D. Pereg,et al.  Normal fasting plasma glucose levels and type 2 diabetes in young men. , 2005, The New England journal of medicine.

[41]  John D Sorkin,et al.  The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. , 2005, Diabetes care.

[42]  Juanjuan Fan,et al.  Bimodality of 2-h plasma glucose distributions in whites: the Rancho Bernardo study. , 2005, Diabetes care.

[43]  Heejung Bang,et al.  Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. , 2005, Diabetes care.

[44]  V. Vaccarino,et al.  All Pre-Diabetes Is Not the Same: Metabolic and Vascular Risks of Impaired Fasting Glucose at 100 Versus 110 mg/dl , 2006, Diabetes Care.

[45]  Martin J Shipley,et al.  Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. , 2006, Diabetes care.

[46]  B. Balkau,et al.  The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group , 2006, Diabetologia.

[47]  R. DeFronzo,et al.  Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance , 2006, Diabetes.

[48]  P. Zimmet,et al.  Diagnosis and classification of diabetes mellitus , 2002 .